RuDo Logo
Talk to an adviser

Bandhan Healthcare Fund

Pharma and Healthcare · Direct plan · Growth

₹11.69

+₹0.08 (+0.71%) today

NAV on 20 Nov 2026Near its 52-week high

This fund +16.85%BSE Healthcare +18.64%past 5 days

Returns

Up to a year

PeriodThis fundBSE HealthcareRank
1 month+10.22%+11.49%15/19
3 months+3.17%+5.00%14/18
6 months+11.81%+11.71%13/18
This year+19.22%+21.57%14/18
1 year–+19.35%–

Longer term

This fundBSE Healthcare
TotalA yearA yearRank
2 years––+12.1%–
3 years––+21.6%–
5 years––+15.9%–
7 years––+22.0%–
10 years––+13.4%–

From the plan's own NAV, to 20 Nov 2026. Rank 1 is best. Past returns are no guide to the future.

RiskWorst fall -10.1% · volatility 16.6% a year

Volatility, since launch

16.6%

BSE Healthcare 16.1%

Worst fall

-10.1%

Oct 2026, back by Nov 2026

Up months

58%

last 3 years

Against other pharma and healthcare funds, last 3 years (worst fall: 5 years)

Yearly cost

= 1.25%

About average · average 1.10%

13 of 18

More measures ›

Sharpe ratio, 3 years

N/A

Return above the CRISIL Overnight Index per unit of volatility

Sortino ratio, 3 years

N/A

The same, counting only falls

Alpha vs BSE Healthcare

N/A

Yearly return beyond what its beta explains

Beta vs BSE Healthcare

N/A

Moves this much when the index moves 1%

Share of the index's rises

100%

In months the index rose

Share of the index's falls

110%

In months the index fell; lower is better

Over the last 3 years, from the fund's NAVs against the BSE Healthcare.

Where it ranksAgainst 19 pharma and healthcare funds

Where it ranks

among 19 pharma and healthcare funds, Direct plans

Lowest cost

13 of 18

Third quarter

Best over 3 years3 yearsCost
1HDFC Pharma and Healthcare Fund+123.0%1.04%
2SBI Healthcare Opportunities Fund+94.4%1.00%
3Mirae Asset Healthcare Fund+90.9%0.61%
4UTI Healthcare Fund+87.3%1.34%
5LIC MF Healthcare Fund+80.9%1.38%
18Bandhan Healthcare Fund this fund–1.25%

Every fund in the category computed from its own NAV the same way, to 20 Nov 2026. All Pharma and Healthcare funds ›

What stands out

What it holds

37 holdings · as of Aug 2026

  1. 1Sun Pharmaceutical Industries Ltd10.48%
  2. 2Cipla Ltd6.38%
  3. 3Max Healthcare Institute Ltd5.81%
  4. 4Apollo Hospitals Enterprises Ltd5.64%
  5. 5Cash, TREPS and repo4.33%
  6. 6Divi'S Laboratories Ltd4.28%
  7. 7Aurobindo Pharma Ltd4.14%
  8. 8Lupin Ltd3.96%
  9. 9Shilpa Medicare Ltd3.72%
  10. 10Glaxosmithkline Pharmaceuticals Ltd3.68%
Top 10: 52.4% of the fund
P/E 47.5 · Turnover 55% a yearCheck overlap with another fund ›

SIP returns of pharma and healthcare funds · All pharma and healthcare funds · Fund screener

About Bandhan Healthcare Fund Direct Plan Growth

Bandhan Healthcare Fund Direct Plan Growth is a Sector Specific - Pharma equity fund from Bandhan AMC Limited, launched on 24 Nov 2025. Its benchmark is the BSE Healthcare Index. The expense ratio is 1.25% a year. It manages ₹325 crore. The NAV was ₹11.69 on 20 Nov 2026.

Questions about Bandhan Healthcare Fund

What is the NAV of Bandhan Healthcare Fund Direct Growth?

The NAV of Bandhan Healthcare Fund Direct Growth was ₹11.69 on 20 Nov 2026. Mutual fund NAVs are published once a day, after markets close.

What is the expense ratio of Bandhan Healthcare Fund Direct Growth?

1.25% a year. It is taken from the fund's assets every day, so the NAV and every return shown are already after this cost.

Can NRIs in the UAE invest in Bandhan Healthcare Fund?

NRIs can generally invest once KYC is complete, paying from an NRE or NRO account. Bandhan Mutual Fund accepts investors living in the US only on conditions and does not accept investors living in Canada, per its own documents checked on 15 Nov 2026. Rules change, so confirm with the fund house.

How are Bandhan Healthcare Fund gains taxed for NRIs?

India taxes gains on equity funds at 20% on units held 12 months or less, and at 12.5% on gains above ₹1.25 lakh a year on units held longer, plus cess and any surcharge. For NRIs the tax is deducted when units are redeemed. The UAE has no personal income tax, and the India UAE tax treaty may apply, so confirm your position with a tax adviser.

Rolling returns shows every period, not just the latest.

Compare every pharma and healthcare fund on returns, volatility, worst fall and cost.

Investing from the UAE. NRIs can generally invest once KYC is complete, paying from an NRE or NRO account. Some fund houses restrict residents of the US and Canada. India taxes equity fund gains at 20% on units held 12 months or less and 12.5% above ₹1.25 lakh a year after that, plus cess and any surcharge, deducted when an NRI redeems. The UAE has no personal income tax and the India UAE treaty may apply, so confirm your position with a tax adviser.

Data from RuDo Wealth fund analytics, NAV as of 20 Nov 2026; benchmark as named by Bandhan AMC Limited. India: RuDo Wealth Investment Advisory, SEBI Registered Investment Adviser, registration INA000019503. UAE: RuDo Digital Wealth, FSRA Financial Services Permission 220155, Category 3C (Retail), ADGM. General information, not a recommendation to buy or sell this fund. Past performance does not indicate future returns.